👉 Visit https://oncoassist.com/ to streamline patient care with cutting-edge tools, guidelines, and calculators!
🔬In this episode of Oncology Spotlight, we sit down with Katy Winckworth-Prejsnar, Director of the Global Program at NCCN (National Comprehensive Cancer Network). Katy offers a behind-the-scenes look at how NCCN’s guidelines are being adapted and implemented globally especially in low- and middle-income countries.
She speaks on equity in access to cancer care, the challenges and opportunities in global implementation of NCCN Guidelines, and her unique path into oncology from a background in cancer genetics, community outreach, and health equity.
🧭 What you’ll learn in this episode:
The mission of NCCN’s Global Program and its real-world impact
How local adaptation of guidelines empowers low-resource settings
Challenges in global cancer guideline dissemination
Why policy, education, and advocacy are just as important as treatment
Katy's powerful career journey into global oncology
🎧 Listen now and get inspired by how strategic collaboration and culturally informed adaptations are shaping the future of oncology around the world.
Connect with Katy Winckworth-Prejsnar here: https://www.linkedin.com/in/katywinckworthprejsnar/
📲 Oncology at your fingertips.
Download the ONCOassist app:
📥 iOS: https://apple.co/4iuMxfS
📥 Android: https://bit.ly/oncoassistonandroid
📥Webapp: https://bit.ly/ONCOassistOnWeb
🚀 SUBSCRIBE to the ONCOassist Podcast for more expert insights!
🔔 Turn on notifications so you never miss an episode.
📌 FOLLOW US FOR UPDATES:
📍 LinkedIn: https://bit.ly/oncoassistlinkedin
📍 Twitter/X: https://bit.ly/oncoassisttwitter
👉 Visit https://oncoassist.com/ to streamline patient care with cutting-edge tools, guidelines, and calculators!
🔬We sit down with Dr. Douglas Flora, Executive Medical Director at St. Elizabeth Healthcare and Editor-in-Chief of the AI in Precision Oncology Journal. In this episode, Dr. Flora shares how artificial intelligence is revolutionizing oncology, from early detection and precision treatment to the importance of human-centered care in an increasingly tech-driven world.
Dr. Flora shares his candid insights on:
How AI is being used in cancer detection and diagnostics
The ethical challenges of integrating AI into clinical practice
Why human connection remains at the heart of great cancer care
Building emotionally intelligent care teams
Leadership lessons from years on the front lines of oncology
The mission behind the AI in Precision Oncology Journal
🧠 “AI won’t replace oncologists — it’ll empower them.”
📌 Don’t miss this powerful discussion on the intersection of compassion, tech, and cutting-edge cancer care.
Connect with Dr. Douglas Flora here: https://www.linkedin.com/in/douglasflora/
Ai in Precision Oncology Journal: https://home.liebertpub.com/publications/ai-in-precision-oncology/679
📢 JOIN THE CONVERSATION! ❓Drop your thoughts in the comments below!📲 Oncology at your fingertips.
Download the ONCOassist app:
📥 iOS: https://apple.co/4iuMxfS
📥 Android: https://bit.ly/oncoassistonandroid
📥Webapp: https://bit.ly/ONCOassistOnWeb
🚀 SUBSCRIBE to the ONCOassist Youtube Channel for more expert insights!🔔 Turn on notifications so you never miss an episode.
📌 FOLLOW US FOR UPDATES: 📍 LinkedIn: https://bit.ly/oncoassistlinkedin
📍 Twitter/X: https://bit.ly/oncoassisttwitter
👉 Visit https://oncoassist.com/ to streamline patient care with cutting-edge tools, guidelines, and calculators!
🔬Step into the inspiring journey of Dr. Paul O’Brien, an Irish medical professional whose career has spanned continents and disciplines, from food science to clinical medicine, from China to Ireland, and from the wards to the digital frontlines of misinformation.
In this episode of Oncology Spotlight, Dr. Paul O’Brien opens up about:
- His unconventional journey into medicine
- What training in China taught him about resilience
- The open letter that made national headlines
- Why physicians must reclaim the narrative on social media
- The danger of pseudoscience & viral medical influencers
- Practical use of AI in daily clinical decision-making
- Mobilising support during the COVID-19 crisis
🧠 Insightful. Unfiltered. Timely. This is a must-watch for every clinician navigating the evolving intersection of medicine, media, and AI.
Connect with Dr. Paul O’Brien here: https://www.linkedin.com/in/pgobrien/
Irish Examiner Article: https://www.irishexaminer.com/special-reports/arid-41419660.html
📌 CHAPTERS & TIMESTAMPS
⏳[00:00] – Introduction & Welcome
👨⚕️ [00:28] – Dr. O’Brien’s Background
🌏 [00:54] – Inspiration to pursue a career in Medicine
🍱 [03:08] – Journey from Ireland to China and back again
💡 [06:00] – Choice or chance to study in China
🧠 [07:07] – Interest in Food Science
📺 [10:56] – Irish Examiner Feature & National Media Attention
🦠 [14:08] – Helping Ireland from China During COVID
📲 [14:54] – Content Creation & The Role of Doctors on Social Media
💻[17:05] – Gary Brecka, Brian Johnson & Combating Medical Misinformation
🏥 [19:20] – Healthcare Reform & Access Challenges in Ireland
🤖 [21:34] – Using AI Tools Like ChatGPT & Heidi in Clinical Practice
🔚 [24:29] – Final Thoughts & Closing Remarks
📲 Oncology at your fingertips.
Download the ONCOassist app:
📥 iOS: https://apple.co/4iuMxfS
📥 Android: https://bit.ly/oncoassistonandroid
📥Webapp: https://bit.ly/ONCOassistOnWeb
🚀 SUBSCRIBE to the ONCOassist Youtube Channel for more expert insights!🔔 Turn on notifications so you never miss an episode.
📌 FOLLOW US FOR UPDATES: 📍 LinkedIn: https://bit.ly/oncoassistlinkedin
📍 Twitter/X: https://bit.ly/oncoassisttwitter
👉 Visit https://oncoassist.com/ to streamline patient care with cutting-edge tools, guidelines, and calculators!
🎧 In this episode of Oncology Spotlight, we’re joined by Dr. Jiten Jaipuria, uro-oncologist and focal therapy specialist at Portsmouth Hospitals University NHS Trust, to explore a critical but often under-discussed topic: radiorecurrent prostate cancer.
With recurrence becoming more common in the era of precision oncology, Dr. Jaipuria explains:
How radiorecurrent prostate cancer is defined
The role of the Phoenix criteria and PSA thresholds
The growing importance of imaging (PSMA PET/MRI)
How to approach salvage therapies like cryotherapy, HIFU, brachytherapy, and more
Why a personalised treatment strategy is essential in recurrent cases
💬 “We have more tools than ever. It’s about picking the right one for the right patient.”
This is a must-listen for urologists, oncologists, radiotherapists, and care teams managing recurrent prostate cancer cases.
📢 JOIN THE CONVERSATION! ❓ What do you think is the biggest challenge in oncology nursing today? Drop your thoughts in the comments below!📲 Oncology at your fingertips.
Download the ONCOassist app:
📥 iOS: https://apple.co/4iuMxfS
📥 Android: https://bit.ly/oncoassistonandroid
📥Webapp: https://bit.ly/ONCOassistOnWeb
🌐 Learn more at: https://oncoassist.com/
🚀 SUBSCRIBE to the ONCOassist Youtube Channel for more expert insights!
🔔 Turn on notifications so you never miss an episode.
📌 FOLLOW US FOR UPDATES:
📍 LinkedIn: https://bit.ly/oncoassistlinkedin
📍 Twitter/X: https://bit.ly/oncoassisttwitter
#OncologySpotlight #ProstateCancer #RadiorecurrentProstateCancer #FocalTherapy #SalvageTherapy #RoboticSurgery #UroOncology #PSMAPET #OncoAlert
👉 Visit https://oncoassist.com/ to streamline patient care with cutting-edge tools, guidelines, and calculators!
🔬In this powerful episode, we’re joined by Dr. Akash Maniam, a UK-based medical oncologist whose work spans urological and breast cancers, with a strong focus on health equity, global access, and digital innovation.
🧠 From his experience in both the UK and the Caribbean, Dr. Maniam discusses:
Structural gaps in global oncology systems
How AI and digital health can bridge access inequalities
Unique challenges refugees face when battling cancer
Strategies for global collaboration and patient empowerment
The founding and vision behind IUCS – International Urology Cancer Summit
🌍 With real-world insight and a passion for progress, Dr. Maniam shares practical ways we can make cancer care more inclusive, accessible, and future-ready.
📄 Further Reading – His Editorial: 🔗 “Refugees Have Cancer Too” – https://ecancer.org/en/journal/editorial/134-refugees-have-cancer-too
🌐 TeleHelp Ukraine – Website & Contact Information
Website: https://telehelpukraine.com
Contact Email: info@telehelpukraine.com
Services: Provides free teleconsultations for Ukrainian patients, including oncology support.
Download the ONCOassist app:
📥 iOS: https://apple.co/4iuMxfS
📥 Android: https://bit.ly/oncoassistonandroid
🚀 SUBSCRIBE to the ONCOassist Youtube Channel for more expert insights!
🔔 Turn on notifications so you never miss an episode.
📌 FOLLOW US FOR UPDATES:
📍 LinkedIn: https://bit.ly/oncoassistlinkedin
📍 Twitter/X: https://bit.ly/oncoassisttwitter
Visit https://oncoassist.com/ to streamline patient care with cutting-edge tools, guidelines, and calculators!
In this episode of Oncology Spotlight, we sit down with Aileen O'Meara, an Advanced Nurse Practitioner in Medical Oncology at St. Vincent's Hospital, Dublin, with over 30 years of experience in oncology nursing. Aileen shares invaluable insights into the changing landscape of cancer treatment, the role of advanced nurse practitioners, and the impact of immunotherapy on patient care.
From discussing common immunotherapy side effects (irAEs) to new innovations in oncology nursing, this episode is packed with expert insights that every oncologist, nurse, and healthcare professional should hear.
Listen now to learn:
✅ How oncology nursing has evolved over the years
✅ The role of Advanced Nurse Practitioners in cancer treatment
✅ Managing immune-related adverse events (irAEs) in patients
✅ How nurses differentiate side effects of immunotherapy vs. chemotherapy
✅ The latest oncology innovations & future treatment trends
✅ The role of AI & technology in supporting oncology nurses
🔹 Watch on Youtube: https://youtu.be/2by9BxX-tTA
📢 JOIN THE CONVERSATION! ❓ What do you think is the biggest challenge in oncology nursing today? Drop your thoughts in the comments below!📲 Oncology at your fingertips.
Download the ONCOassist app:
📥 iOS: https://apple.co/4iuMxfS
📥 Android: https://bit.ly/oncoassistonandroid
🚀 SUBSCRIBE to the ONCOassist Youtube Channel for more expert insights! 🔔 Turn on notifications so you never miss an episode.
📌 FOLLOW US FOR UPDATES:
📍 LinkedIn: https://bit.ly/oncoassistlinkedin
📍 Twitter/X: https://bit.ly/oncoassisttwitter
We hope you enjoyed the episode.
Thank you for being a part of ONCOassist.
In this episode of the Oncology Spotlight podcast, we are honored to host Prof. Keith Kerr, a Consultant Pathologist at Aberdeen Royal Infirmary and Honorary Professor at the University of Aberdeen. With over 35 years of experience in thoracic pathology, Prof. Kerr is a globally recognized expert in non-small cell lung cancer (NSCLC), particularly in predictive and diagnostic biomarkers, immunotherapy, and personalized medicine.
Join us as Prof. Kerr shares his remarkable journey from medical school to becoming a leading pathologist specializing in thoracic oncology. In this insightful conversation, he delves into:
His Path to Pathology: Discover what led Prof. Kerr to specialize in thoracic oncology and how a pivotal research project in lung cancer set the course for his distinguished career.
Understanding Reflex Testing in NSCLC: Prof. Kerr explains the concept of reflex testing, why it’s essential in the timely and accurate diagnosis of lung cancer, and how it has transformed patient care by ensuring that crucial molecular and biomarker tests are conducted without delay.
The Impact of New Treatment Options: Learn how the advent of targeted therapies and immunotherapies for NSCLC has increased the importance of reflex testing and how it’s applied in current clinical practices.
Challenges and Contributions to Lung Cancer Guidelines: Prof. Kerr shares his experiences and challenges in contributing to numerous national and international lung cancer guidelines, offering a unique perspective on the evolving standards in lung cancer diagnosis and treatment.
Future of Pathology and the Role of AI: Prof. Kerr also discusses the future of pathology training, especially with the integration of new technologies and artificial intelligence in diagnostics, particularly for lung cancer.
Whether you're a healthcare professional, a student, or simply interested in the latest advancements in oncology, this episode offers valuable insights into the evolving field of lung cancer diagnosis and treatment.For inquiries, contact us at info@oncoassist.com
Let's connect:
Website: www.oncoassist.com
Twitter: https://twitter.com/oncoassist
LinkedIn: https://www.linkedin.com/showcase/oncoassist-oncology-decision-support-tool
Instagram:https://www.instagram.com/oncoassist/
Facebook: https://www.facebook.com/ONCOassist
Welcome to another episode of the Oncology Spotlight Podcast! In this episode, we're thrilled to have Eoin Tabb, Chief 2 Pharmacist specializing in Clinical Cancer Services at University Hospital Waterford, Ireland, as our guest. Eoin is a passionate advocate for digital health transformation, leading a team dedicated to enhancing the safety and efficiency of cancer care.
In this insightful conversation, Eoin shares his journey to becoming an oncology pharmacist, his specialization in cancer care, and how digital health is revolutionizing oncology today and in the future. We also dive into his work with The Irish Haematology Oncology Podcast, a jargon-free exploration of cancer care, designed to educate healthcare professionals and enthusiasts alike.
Key Discussion Points:
Eoin’s background and journey to becoming a pharmacist
Specializing in cancer care and the reasons behind it
The impact of digital health transformation on cancer care today and its future potential
The inspiration and goals behind The Irish Haematology Oncology Podcast
Challenges faced by oncology professionals today
How digital tools are helping to address these challenges
The potential opportunities for AI in oncology
Eoin’s aspirations for advancing cancer care through his current role and broader initiatives
Whether you’re a healthcare professional, digital health enthusiast, or simply interested in the future of cancer care, this episode offers valuable insights.
👉 Don’t forget to like, comment, and subscribe to our channel for more insightful episodes!🔔 Turn on notifications so you never miss an update.
🔗 Links:
Listen to The Irish Haematology Oncology Podcast:
Connect with Eoin Tabb on LinkedIn:
For inquiries, contact us at info@oncoassist.com
Let's connect:
Website: www.oncoassist.com
Twitter: https://twitter.com/oncoassist
LinkedIn: https://www.linkedin.com/showcase/oncoassist-oncology-decision-support-tool
Instagram:https://www.instagram.com/oncoassist/
Facebook: https://www.facebook.com/ONCOassist
Welcome to the Oncology Spotlight! In this episode, join us as we delve into the forefront of cancer care with Professor Gerry Hanna, a distinguished radiation oncologist and Marie Curie Chair of Clinical Oncology at Trinity College Dublin.
Key Discussion Points:
Introduction: Get to know Professor Gerry Hanna and his illustrious career spanning leading institutions like Queen’s University Belfast and the University of Melbourne.
Latest Developments in Lung Cancer Treatment: Professor Hanna shares groundbreaking advancements shaping the future of lung cancer care.
Evolution of CRT in Lung Cancer: Discover insights into how Combined Radiation Therapy (CRT) has progressed over the past five years.
Interpreting Scans Post-CRT: Learn about challenges and strategies in interpreting scans, especially in conjunction with immunotherapy.
Emerging Guidelines for Scan Interpretation: Professor Hanna outlines emerging best practices crucial for accurate treatment decisions.
Role of Multidisciplinary Teams (MDT): Understand the pivotal role MDTs play in enhancing diagnostic accuracy and treatment planning.
Current Research Initiatives: Explore ongoing research projects like PERTAIN and CONCORDE and their potential impact on cancer care.
Challenges in Oncology Today: Professor Hanna discusses the significant challenges facing oncology and strategies to overcome them.
Future Prospects with AI: Gain insights into the promising intersection of oncology and artificial intelligence (AI).
Don't miss this enlightening conversation that promises to deepen your understanding of cutting-edge oncology practices and future directions in cancer treatment.
🎧 Listen to the full podcast episode: LINK and join the conversation!
🔬 Join us in this insightful conversation with Dr. Arturo Loaiza-Bonilla, Chief Medical Officer at MassiveBio, as he shares his journey and expertise in the ever-evolving landscape of oncology and artificial intelligence. 🚀
🌐 MassiveBio is at the forefront of transforming cancer care, leveraging AI to optimize workflows, enhance clinical trial matching, and revolutionize drug discovery. Dr. Loaiza-Bonilla delves into his experiences with ontology-based approaches, NLP, OCR, and the emergence of large AI models like GPT-3.
📈 Discover the potential of multi-modal approaches for prognostication in clinical trials and the groundbreaking use of AI in oncology research. Dr. Loaiza-Bonilla emphasizes the need for collaborative efforts to streamline processes, from patient recruitment to post-enrollment engagement.
🤖 As we explore the impact of AI in healthcare, Dr. Loaiza-Bonilla addresses the challenges in adoption, emphasizing the importance of regulatory clarity, incentives, and avoiding the fear of technology replacing human expertise.
👩⚕️ Dive into the heart of oncology challenges, where Dr. Loaiza-Bonilla sheds light on the fundamental need for improved biomarker testing. He advocates for patient-centric approaches, automated processes, and removing hurdles to ensure timely and accurate testing.
🌟 Exciting Advances in Cancer Treatment! Dr. Loaiza-Bonilla discusses recent breakthroughs, including bispecific antibodies, gene editing with CRISPR, and the promising developments in ADCs (antibody-drug conjugates). Learn how AI plays a pivotal role in accelerating drug efficacy assessments and in silico trials.
🎗️ Advice for Patients and Caregivers: Dr. Loaiza-Bonilla encourages individuals to be their own advocates, stressing the importance of asking questions, exploring biomarker-driven options, and planning for various treatment scenarios. Remember, your life is your journey, and collaboration with your healthcare team is key.
👨⚕️ Dr. Arturo Loaiza-Bonilla's insights are invaluable, providing a glimpse into the future of cancer care and the pivotal role AI plays in advancing treatments. Don't miss out on this engaging and informative conversation!
🔔 Subscribe for more updates on healthcare innovations, AI in medicine, and inspiring conversations with leading experts. Let's empower patients and caregivers on their cancer journey together!
#AIinOncology #CancerTreatment #HealthcareInnovations #MassiveBio #DrArturoLoaizaBonilla #AIRevolution
🌱 Explore the groundbreaking research on the intersection of food and immunotherapy in the latest episode of Oncology Spotlight. Join Dr. Sandrine Aspeslagh, a leading Medical Oncologist, as she shares insights into her work, from the early days of immunotherapy to innovative approaches in managing immune-related adverse events.
🎙️ In this episode, discover the FORX research program, which aims to reduce immune-related adverse events through high-fiber diets. Sandrine discusses the motivations behind this research, its potential impact on patient care, and the challenges faced in pioneering this approach.
🌍 Support this transformative initiative by contributing to our crowdfunding campaign as we strive to empower patients through personalized dietary strategies. For Belgian citizens, your contribution is tax-deductible.
🔗 Crowdfunding Campaign: https://bit.ly/FORX_
📖 Don't miss this eye-opening conversation that goes beyond traditional cancer care.
🎙️ On today’s episode of Oncology Spotlight we’re stepping into the world of oncology care with Michelle Matthews and Anne-Marie Fay, the compassionate hosts behind the Answers for Cancers podcast. In this heartwarming interview, Michelle, deeply involved in cancer research, shares her journey to oncology, while Anne-Marie, transitioning from intensive care, offers a unique perspective gained from working with breast cancer patients.
👩⚕️ As they reflect on their nursing careers, these hosts open up about the profound personal connections that drew them to the field, influenced by family illnesses. Michelle's transition from teaching to nursing is explored, along with pivotal training experiences that shaped their paths, particularly encounters with oncology patients.
🌟 Sharing the joyous aspects of their work, Michelle and Anne-Marie emphasize the deep connections formed with patients, expressing gratitude for the meaningful friendships forged in the healthcare community. They delve into the origins of their podcast, The Answers for Cancers, revealing its evolution from a nurse-focused initiative to a platform centered on empowering patients.
🌍 The hosts discuss the global impact of their podcast, covering diverse topics such as lymphedema and psycho-oncology. Looking ahead, they express enthusiasm about the future of oncology, highlighting advancements in clinical trials. Michelle specifically shares her optimism regarding targeted therapies in breast cancer.
💡 In a warm message to patients and caregivers navigating the complexities of cancer care, Michelle and Anne-Marie offer valuable insights, underscoring the delicate balance needed when sharing information. Subscribe to their podcast for uplifting conversations and expert perspectives on cancer care: https://open.spotify.com/show/3BFSTkbPcbzHDKvWm2COYj?si=bdf37bec650a4b83
Welcome to "Oncology Spotlight"! In this episode, we shine light on blood cancer awareness, featuring an exclusive interview with Dr. Hisam Siddiqi, founder of Bread & Butter Hematology, a distinguished figure in the field of haematology.
Join us as Dr. Siddiqi provides insights into his inspiring journey in medicine, delving into what sparked his passion for this field and why he chose to specialize in haematology. Discover the story behind the creation of "Bread & Butter Hematology," a unique initiative that has been making waves in the haematology community.
Learn about the vision and future plans for "Bread & Butter Hematology," and gain valuable insights into the future of haematology as Hisam Siddiqi shares his perspectives on the most groundbreaking developments and areas of focus in the upcoming decade.
Discover how patient-centered care and support form the cornerstone of Dr. Siddiqi's approach towards individuals dealing with haematology-related challenges. Gain a deeper understanding of the significant obstacles and challenges that haematology professionals face in current medical practice.
Stay tuned as Dr. Siddiqi graciously shares more about the fascinating world of haematology, offering a glimpse into upcoming projects that are set to make a difference. 🌟
🎙️ For more engaging discussions and expert insights, don't forget to subscribe to "Oncology Spotlight".
Welcome to 'Oncology Spotlight,' where we illuminate the world of haematology and dive deep into its intricacies with an inspiring guest, Geraldine Walpole. As a Registered Advanced Nurse Practitioner in Haematology and the Chairperson of Multiple Myeloma Ireland, Geraldine brings a unique perspective to our discussion.
In this episode, Geraldine shares her background, the motivation behind her nursing career, and what led her to specialize in haematology. We also explore the critical initiatives and support services Multiple Myeloma Ireland provides to patients, shedding light on the significance of patient support groups in the journey of those facing haematologic disorders.
Advancements in haematology are a crucial aspect, and Geraldine offers insights into recent breakthroughs in myeloma treatment. Additionally, we discuss the importance of continuous education for healthcare professionals and the challenges faced in haematology care, along with possible solutions.
Collaboration and multidisciplinary care are key components of patient well-being, and Geraldine elaborates on how she collaborates with haematologists and oncologists to ensure comprehensive care. Looking to the future, we explore promising developments and trends in the field of haematology.
Join us in this illuminating conversation, gaining insights from Geraldine's wealth of experience and dedication to improving lives in the realm of haematology.
🎙️ Welcome to another captivating episode of Oncology Spotlight! 🌟
In this episode, we delve deep into the realm of haematology, where groundbreaking discoveries are transforming patient care. Today, we have the honor of hosting, Dr. Liam Smyth, whose career has been dedicated to the study and treatment of haematological disorders.
🩸 Here's a sneak peek at what we'll be discussing:
Introduction and Background:
🔬 Dr. Smyth gives us a glimpse into his remarkable journey and what led him to a career in medicine.
Advancements in Haematology:
🚀 Find out which recent breakthroughs in haematology have left Dr. Smyth excited and inspired.
Lymphoma and Immunotherapies:
🦠 Learn about the pivotal role of immunotherapies in lymphoma treatment, including exciting ongoing clinical trials.
Patient-Centered Care:
❤️ Explore Dr. Smyth's approach to providing not only medical treatment but also emotional support to patients facing haematological disorders.
Collaborative Approach:
🤝 Understand the importance of collaboration among haematologists, oncologists, and other professionals for comprehensive patient care.
Education and Outreach:
📚 Discover common misconceptions about haematological disorders and gain insights into Dr. Smyth's approach to staying updated with the latest developments.
Personal Reflections:
🌟 Hear a heartwarming patient success story that reaffirmed Dr. Smyth's dedication to haematology.
Closing:
🎤 Dr. Smyth shares his final thoughts on haematology, advancements in treatment, and his personal journey in the field.
Join us on this enlightening journey of knowledge and discovery with Dr. Liam Smyth as your guide. Don't miss this opportunity to gain valuable insights into the world of haematology and the future of patient care.
🔗 Stay tuned and subscribe for more engaging episodes of Oncology Spotlight. Let's begin! 🎧👨⚕️🩺
Disclaimer: Please note that Amgen Ireland has kindly supported the creation of this video. However, ONCOassist has full control over the content created.
Greetings and a warm welcome to the Oncology Spotlight!
We’re thrilled to introduce the highly esteemed CEO of Cancer Trials Ireland, Mrs. Eibhlín Mulroe. Mrs. Mulroe is a prominent figure in the healthcare industry, recognized for her vast experience and expertise in clinical research and eHealth initiatives.
As the CEO of Cancer Trials Ireland, Mrs. Mulroe has played a critical role in advancing clinical research in Ireland. Her contribution to the healthcare sector extends beyond her role as CEO, as she also serves on the eHealth Ireland Committee, where she plays an instrumental role in supporting the implementation of the Irish government's Ehealth Strategy. Additionally, she serves as an Advisory Board member of the Cork Clinical Research Centre.
Without further ado, let's delve into an insightful conversation with the brilliant Mrs. Eibhlín Mulroe, CEO of Cancer Trials Ireland! 🎙️
🏥 Healthcare Journey:
Mrs. Mulroe, could you share with us how your journey in the healthcare industry led you to your current role as the CEO of Cancer Trials Ireland?
⏰ A Day in the Life:
Ever wondered what a typical day looks like for a powerhouse like Mrs. Mulroe? Stick around as we ask her to give us a sneak peek into her busy schedule and how she manages her role as CEO. 📅
💪 Advancing Cancer Treatment:
Clinical trials play a pivotal role in shaping the future of cancer treatment. Join us as Mrs. Mulroe sheds light on the significance of clinical trials and how Cancer Trials Ireland is contributing to this crucial effort. 🩺
📈 Changing Landscape:
The world of cancer trials has transformed significantly over the last two decades. Let's hear from Mrs. Mulroe on how these changes have impacted Ireland and the global scene. 🌎
🧠 Lessons and Learning:
Taking on the role of CEO brings its own set of challenges and growth opportunities. Discover the most profound lessons Mrs. Mulroe has learned during her time at the helm of Cancer Trials Ireland. 📚
🎯 Strategic Objectives:
What are the strategic objectives that Cancer Trials Ireland aims to achieve from 2022 to 2027? Mrs. Mulroe provides insight into the organization's plans for the future. 📊
🌿 Greening Cancer Trials:
A unique initiative by Cancer Trials Ireland, the Greening Cancer Trials initiative, holds great promise. Tune in as we learn more about this environmentally conscious approach to advancing cancer research. 🌱
🚀 Future Initiatives:
What's on the horizon for Cancer Trials Ireland? Mrs. Mulroe unveils upcoming projects and initiatives, offering a glimpse into how the organization is evolving to meet future challenges. 🔍
🌟 Advice for Future Researchers:
Calling all aspiring professionals in clinical research! Mrs. Mulroe imparts valuable advice for those looking to make a positive impact in this dynamic field. 🌟
🔔 Don't forget to hit that notification bell so you never miss out on our engaging interviews with industry leaders like Mrs. Eibhlín Mulroe! Like, share, and subscribe for more enriching content. Stay inspired and informed! 📢
Disclaimer: Please note that MSD Ireland has kindly supported the creation of this video. However, ONCOassist has full control over the content created.
Welcome to "Oncology Spotlight" featuring Dr. Vishal Rao, a distinguished oncologist and expert in head and neck surgical oncology. Dr. Rao is a committed advocate for innovative and patient-centred care, bringing advanced treatments to patients not just in India but all over the world. In this podcast, we will hear about Dr. Rao's inspiring journey, his groundbreaking work, and his vision for the future of cancer care.
Dr. Rao's impressive background in surgery, research, and education has led to significant contributions in the field of oncology. He will talk about what inspired him to pursue surgical oncology and the most rewarding aspects of his work. He has also done extensive research on a low-cost device for the early detection of oral cancer and its potential impact on cancer prevention.
As an award-winning physician, Dr. Rao shares his proudest achievement, and he also speaks about his non-profit organization, Swasthya Cancer Sahyog, which provides cancer screening and treatment to underserved communities.
Dr. Rao discusses the biggest challenges that the field of oncology faces today and how technology is changing the way cancer is diagnosed and treated. He also shares his vision for the future of cancer treatment and prevention and the advancements that will have the greatest impact on patient outcomes.
As oncology continues to evolve in India and globally, Dr. Rao discusses the role of initiatives and programs aimed at improving cancer care and treatment access in underprivileged communities. For aspiring medical professionals interested in the field of oncology, Dr. Rao provides valuable advice, and for patients and caregivers navigating cancer care, he shares his tips.
Join us as we delve into the world of oncology with Dr. Vishal Rao, an inspiring and innovative leader in the field. And, Dr. Rao would be happy to share his knowledge and experience with you, so stay tuned.
Disclaimer: Please note that MSD Ireland has kindly supported the creation of this video. However, ONCOassist has full control over the content created.
Find out more about Dr. Vishal Rao:
Website: https://drvishalrao.in
LinkedIn: https://www.linkedin.com/in/drvishalrao/Twitter: https://twitter.com/drvishalrao
G-Scholar: https://scholar.google.com/citations?user=N2jofFgAAAAJ&hl=en
Instagram: https://www.instagram.com/vishalrao/
Facebook: https://www.facebook.com/drvishalrao
For inquiries, contact us at info@oncoassist.com
Let's connect:
Website: www.oncoassist.com
Twitter: https://twitter.com/oncoassist
LinkedIn: https://www.linkedin.com/showcase/oncoassist-oncology-decision-support-tool
Instagram:https://www.instagram.com/oncoassist/
Facebook: https://www.facebook.com/ONCOassist
In today's episode, we have Dr. Michiel Strijbos, a Medical Oncologist and healthcare tech enthusiast, who focuses on the research and treatment of GU malignancies. With several task forces and committees under his belt, Dr. Strijbos is also a principal investigator in various clinical trials.
Aside from his impressive academic background, Dr. Strijbos was the chair of the ESMO Practicing Oncologists Working Group and is a member of the Publishing Group and Educational Committee.
We are thrilled to have Dr. Strijbos here to share his insights and perspectives with us. Join us as we dive into the conversation and learn more about his background, what inspired him to pursue a career in medical oncology, and the most rewarding aspects of his work.
We will also discuss his involvement with ESMO and some of the exciting projects he has worked on, as well as his views on the potential of health tech, including the use of AI in oncology.
Dr. Strijbos will share his thoughts on the biggest challenges facing the field of medical oncology and how he sees them being addressed in the future. He will also discuss some of the recent advances in cancer treatment that he finds particularly exciting and promising.
Finally, for patients and caregivers seeking advice on navigating cancer care, Dr. Strijbos will offer his tips and insights.
So, sit back and enjoy Oncology Spotlight with Dr. Michiel Strijbos.
Disclaimer: Please note that MSD Ireland has kindly supported the creation of this video. However, ONCOassist has full control over the content created.
In this episode of the Oncology Spotlight podcast, we had the pleasure of interviewing Dr. Brendan Noonan, a lecturer and researcher at University College Cork, School of Nursing and Midwifery. Dr. Noonan shares his insights and experiences as an oncology nurse and researcher, and discusses his current and past research papers.
During the conversation, Dr. Noonan talks about his motivation to pursue a career in nursing and oncology, and the importance of creating a patient checklist and evidence-based practice in cancer care.
Dr. Noonan also talks about his involvement in the Liam Mc Trial, a study aimed at improving the quality of life for men with cancer. He shares details about the patient journey on the trial and the type of new information he hopes to learn from the study.
Don't miss this informative and insightful conversation with Dr. Brendan Noonan. Subscribe to the Oncology Spotlight podcast for more episodes featuring leading experts in the field of oncology.
Chapters for youtube:
Find out more about Dr. Brendan Noonan:
LinkedIn: https://www.linkedin.com/in/bjmnoonan/?originalSubdomain=ie
Research Gate: https://www.researchgate.net/profile/Brendan-Noonan
For inquiries, contact us at info@oncoassist.com
Let's connect:
Website: www.oncoassist.com
Twitter: https://twitter.com/oncoassist
LinkedIn: https://www.linkedin.com/showcase/oncoassist-oncology-decision-support-tool
Instagram:https://www.instagram.com/oncoassist/
Facebook: https://www.facebook.com/ONCOassist
